<?xml version="1.0" encoding="US-ASCII"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2enclosuresfull.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
<channel>
<itunes:new-feed-url>http://feeds.feedburner.com/accpodcast</itunes:new-feed-url>
<title>ACC Conversations</title> 
<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
<link>http://www.conversations.acc.org</link>
<itunes:subtitle>American College of Cardiology presents Conversations with Experts, a series of 20-minute interactive discussions between though-leaders on topics of importance to the medical community</itunes:subtitle> 
<itunes:summary> American College of Cardiology presents Conversations with Experts, a series of 20-minute interactive discussions between though-leaders on topics of importance to the medical community </itunes:summary> 
<itunes:keywords>Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</itunes:keywords> 
<language>en-us</language> 
<copyright>C 2005 American College of Cardiology</copyright> 
<itunes:owner>
<itunes:name>ACC Conversations</itunes:name> 
<itunes:email>webmaster@acc.org</itunes:email> 
</itunes:owner>
<itunes:image href="http://www.healthology.biz/acc/podcast/acc_podcast_cover.jpg" /> 
<itunes:category text="Science &amp; Medicine" />

<media:copyright>C 2005 American College of Cardiology</media:copyright><media:thumbnail url="http://www.healthology.biz/acc/podcast/acc_podcast_cover.jpg" /><media:keywords>Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</media:keywords><media:category scheme="http://www.itunes.com/dtds/podcast-1.0.dtd">Science &amp; Medicine</media:category><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.feedburner.com/accpodcast" type="application/rss+xml" /><item>
	<title>Cardiovascular Risk in Post-Bariatric Surgical Patients</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Cardiovascular Risk in Post-Bariatric Surgical Patients</itunes:subtitle> 
	<itunes:summary>In this conversation, Dr. Dolph Hutter discusses the cardiovascular effects of bariatric surgery and also patient selection criteria with Dr. Mary Ann McLaughlin of the Mount Sinai School of Medicine in New York, New York, and Dr. Howard Willens of the University of Miami Miller School of Medicine in Miami, Florida.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/aac_postbariatric_pats.mp3</guid> 
	<pubDate>Tue, 5 February 2008 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>12:55</itunes:duration> 
	<itunes:keywords>Dr. Dolph Hutter, cardiovascular effects of bariatric surgery, Dr. Mary Ann McLaughlin, Mount Sinai School of Medicine, New York, New York,  Dr. Howard Willens, University of Miami Miller School of Medicine,  Miami, Florida.</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/a3fsJHD4Qho/aac_postbariatric_pats.mp3" fileSize="27690322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/a3fsJHD4Qho" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/a3fsJHD4Qho/aac_postbariatric_pats.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/aac_postbariatric_pats.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/a3fsJHD4Qho/aac_postbariatric_pats.mp3" length="27690322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/aac_postbariatric_pats.mp3</feedburner:origEnclosureLink></item>


<item>
	<title>Role of the Cardiologist in the Management of the Morbidly Obese Patient</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Role of the Cardiologist in the Management of the Morbidly Obese Patient</itunes:subtitle> 
	<itunes:summary>In this conversation, Dr. Dolph Hutter discusses weight loss strategies and the clinical impact of significant weigh loss in obese patients with Dr. James de Lemos and Dr. Howard Willens.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_role_cardio_obese.mp3</guid> 
	<pubDate>Mon, 4 February 2008 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>13:05</itunes:duration> 
	<itunes:keywords>Dr. Dolph Hutter, weight loss strategies, Dr. James de Lemos of the University of Texas, Southwestern Medical School in Dallas, Texas and Dr. Howard Willens, of the University of Miami Miller School of Medicine in Miami, Florida</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/NCkL9GIanII/acc_role_cardio_obese.mp3" fileSize="27690322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/NCkL9GIanII" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/NCkL9GIanII/acc_role_cardio_obese.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_role_cardio_obese.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/NCkL9GIanII/acc_role_cardio_obese.mp3" length="27690322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_role_cardio_obese.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>Antithrombotic Choices for Acute Coronary Syndrome Patients Undergoing Invasive Procedures</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Antithrombotic Choices for Acute Coronary Syndrome Patients Undergoing Invasive Procedures</itunes:subtitle> 
	<itunes:summary>A discussion on Antithrombotic Choices for Acute Coronary Syndrome Patients Undergoing Invasive Procedures</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_antithrombotic_invasive.mp3</guid> 
	<pubDate>Tue, 14 August 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>12:31</itunes:duration> 
	<itunes:keywords>discussion, Antithrombotic Choices, Acute Coronary Syndrome, Patients, Undergoing, Invasive Procedures</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/X3gD77tMcGo/acc_antithrombotic_invasive.mp3" fileSize="27690322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/X3gD77tMcGo" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/X3gD77tMcGo/acc_antithrombotic_invasive.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_antithrombotic_invasive.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/X3gD77tMcGo/acc_antithrombotic_invasive.mp3" length="27690322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_antithrombotic_invasive.mp3</feedburner:origEnclosureLink></item>


<item>
	<title>Timing of Glycoprotein IIb/IIIa Inhibitor Use in ACS Patients Undergoing Invasive Procedures</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Timing of Glycoprotein IIb/IIIa Inhibitor Use in ACS Patients Undergoing Invasive Procedures</itunes:subtitle> 
	<itunes:summary>A discussion on Timing of Glycoprotein IIb/IIIa Inhibitor Use in ACS Patients Undergoing Invasive Procedures</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_antithrombotic_choices.mp3</guid> 
	<pubDate>Tue, 7 August 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>10:55</itunes:duration> 
	<itunes:keywords>Timing of Glycoprotein IIb/IIIa, Inhibitor, Use in ACS, Invasive Procedures, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/dD8r1FF_EIE/acc_antithrombotic_choices.mp3" fileSize="20769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/dD8r1FF_EIE" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/dD8r1FF_EIE/acc_antithrombotic_choices.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_antithrombotic_choices.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/dD8r1FF_EIE/acc_antithrombotic_choices.mp3" length="20769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_antithrombotic_choices.mp3</feedburner:origEnclosureLink></item>


<item>
	<title>Update on the ExTRACT-TIMI Data </title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Update on the ExTRACT-TIMI Data (07/2007)</itunes:subtitle> 
	<itunes:summary>New data from three subgroup analyses of "Enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction ..</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_update_timi.mp3</guid> 
	<pubDate>Tue, 31 July 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>15:55</itunes:duration> 
	<itunes:keywords>ACC, Thrombosis, Drug-Eluting Stents, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/kLHVRL39zu4/acc_update_timi.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/kLHVRL39zu4" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/kLHVRL39zu4/acc_update_timi.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_update_timi.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/kLHVRL39zu4/acc_update_timi.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_update_timi.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Early Initiation of Statin Therapy in Acute Coronary Syndromes</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Early Initiation of Statin Therapy in Acute Coronary Syndromes (07/2007)  </itunes:subtitle> 
	<itunes:summary>A discussion on Early Initiation of Statin Therapy in Acute Coronary Syndromes ..</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_targetldl.mp3</guid> 
	<pubDate>Tue, 31 July 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>13:18</itunes:duration> 
	<itunes:keywords>ACC, Early Initiation of Statin Therapy in Acute Coronary Syndromes</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/Hesj5YJWci0/acc_targetldl.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/Hesj5YJWci0" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/Hesj5YJWci0/acc_targetldl.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_targetldl.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/Hesj5YJWci0/acc_targetldl.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_targetldl.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Preventing Late Thrombosis of Drug-Eluting Stents </title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Preventing Late Thrombosis of Drug-Eluting Stents </itunes:subtitle> 
	<itunes:summary>The risk of thrombosis after implantation of drug-eluting stents (DES) persists for a year or more. In contrast, similar risk after implantation of a bare metal stent (BMS) seems ..</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_prevent_thrombosis.mp3</guid> 
	<pubDate>Tue, 19 June 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>14:55</itunes:duration> 
	<itunes:keywords>ACC, Thrombosis, Drug-Eluting Stents, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/3P_3pKTwhIc/acc_prevent_thrombosis.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/3P_3pKTwhIc" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/3P_3pKTwhIc/acc_prevent_thrombosis.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_prevent_thrombosis.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/3P_3pKTwhIc/acc_prevent_thrombosis.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_prevent_thrombosis.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Targeting LDL Cholesterol: Intensive Statin Treatment or Combination Therapy</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Targeting LDL Cholesterol: Intensive Statin Treatment or Combination Therapy</itunes:subtitle> 
	<itunes:summary>Ideally, the target LDL cholesterol (LDL-C) level for healthy patients is less than 100 mg/dL...</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_target_ldl_statin.mp3</guid> 
	<pubDate>Tue, 12 June 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>12:55</itunes:duration> 
	<itunes:keywords>ACC, LDL, Intensive Statin Treatment, Combination Therapy, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/w7spw4XLJ0Q/acc_target_ldl_statin.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/w7spw4XLJ0Q" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/w7spw4XLJ0Q/acc_target_ldl_statin.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_target_ldl_statin.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/w7spw4XLJ0Q/acc_target_ldl_statin.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_target_ldl_statin.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The Rosiglitazone Story: Does the Science Warrant the Attention</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>The Rosiglitazone Story: Does the Science Warrant the Attention</itunes:subtitle> 
	<itunes:summary>Thiazolidinedione drugs are widely prescribed for lowering blood glucose in patients with type 2 diabetes.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_avandia.mp3</guid> 
	<pubDate>Tue, 5 June 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>21:55</itunes:duration> 
	<itunes:keywords>ACC, AHA, Rosiglitazone, Science Warrant, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/heg3hDTsJmQ/acc_avandia.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/heg3hDTsJmQ" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/heg3hDTsJmQ/acc_avandia.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_avandia.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/heg3hDTsJmQ/acc_avandia.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_avandia.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Effective Management of Acute Coronary Syndrome in the Elderly</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Effective Management of Acute Coronary Syndrome in the Elderly</itunes:subtitle> 
	<itunes:summary>Effective Management of Acute Coronary Syndrome in the Elderly</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_manage_acs_elderly.mp3</guid> 
	<pubDate>Tue, 8 May 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>15:35</itunes:duration> 
	<itunes:keywords>ACC, Elderly, Effective Management,Acute Coronary Syndrome, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/on-cp6N5MyM/acc_manage_acs_elderly.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/on-cp6N5MyM" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/on-cp6N5MyM/acc_manage_acs_elderly.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_manage_acs_elderly.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/on-cp6N5MyM/acc_manage_acs_elderly.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_manage_acs_elderly.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Pleiotropic Effects of Statins </title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>Pleiotropic Effects of Statins </itunes:subtitle> 
	<itunes:summary>Lipid altering agents encompass several classes of drugs, including the most widely used HMG CoA reductase (hydroxymethylglutaryl CoA reductase) inhibitors or statins.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_highdose_statins.mp3</guid> 
	<pubDate>Tue, 6 February 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>17:05</itunes:duration> 
	<itunes:keywords>ACC, Statins, Pleiotropic Effects, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/viw8mBoL2v8/acc_highdose_statins.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/viw8mBoL2v8" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/viw8mBoL2v8/acc_highdose_statins.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_highdose_statins.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/viw8mBoL2v8/acc_highdose_statins.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_highdose_statins.mp3</feedburner:origEnclosureLink></item>




<item>
	<title>The ACC/AHA Guidelines Update on Secondary Prevention</title> 
	<itunes:author> Adolph M. Hutter, Jr., MD </itunes:author> 
	<itunes:subtitle>The ACC/AHA Guidelines Update on Secondary Prevention </itunes:subtitle> 
	<itunes:summary>Since the original publication (1995) of the AHA/ACC consensus statement on secondary prevention, key evidence from clinical trials illustrating the need for aggressive risk factor management led to a revision in 2001. Recently, the AHA/ACC guidelines have been revised once again to reflect important clinical trial evidence that further support aggressive risk-reduction therapies for patients with established coronary and other atherosclerotic vascular disease. Joining this conversation to discuss the new guidelines and their potential impact on clinical practice are Dr Sidney Smith and Dr Robert Bonow, both authors on the AHA/ACC guideline and experts in primary and secondary prevention of cardiovascular disease</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/merck/acc_aha_guidelines.mp3</guid> 
	<pubDate>Tue, 9 Jan 2007 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>18:55</itunes:duration> 
	<itunes:keywords>ACC, AHA, prevention, secondary prevention, guidelines, dolph hutter</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/DMWOyYGlOIs/acc_aha_guidelines.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/DMWOyYGlOIs" height="1" width="1"/&gt;</description><link>http://feedproxy.google.com/~r/accpodcast/~3/DMWOyYGlOIs/acc_aha_guidelines.mp3</link><feedburner:origLink>http://www.healthology.biz/acc/podcast/merck/acc_aha_guidelines.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/DMWOyYGlOIs/acc_aha_guidelines.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/merck/acc_aha_guidelines.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The Role of Statins in Heart Failure</title>
	<link>http://feedproxy.google.com/~r/accpodcast/~3/It6ItV4-7sU/acc_statins.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>The Role of Statins in Heart Failure</itunes:subtitle> 
	<itunes:summary>Several studies have reported improvement in overall outcomes in HF patients treated with statins. The possible mechanisms of benefit, other than treatment of coronary disease that may have been unrecognized, are not known. Joining this conversation to discuss the benefits and possible mechanisms of statin use in patients with heart failure are Dr Steven Nissen, specialist in atherosclerosis and current President of the ACC, and Dr Benjamin Scirica and Dr Marc Pfeffer, both clinical trialists in heart failure.</itunes:summary> 
	
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_statins.mp3</guid> 
	<pubDate>Tue, 19 Dec 2006 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>19:04</itunes:duration> 
	<itunes:keywords>ischemic, non-ischemic, etiologies, heart failure, LDL, endpoints, TNT</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/It6ItV4-7sU/acc_statins.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/It6ItV4-7sU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_statins.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/It6ItV4-7sU/acc_statins.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_statins.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Updates to the Manage of Acute Coronary Syndrome: ExTRACT-TIMI 25 Subgroup Analysis</title>
	<link>http://feedproxy.google.com/~r/accpodcast/~3/i8xLPYXVYvE/acc_update_acc.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author>
	<itunes:subtitle>Updates to the Manage of Acute Coronary Syndrome: ExTRACT-TIMI 25 Subgroup Analysis</itunes:subtitle> 
	<itunes:summary>Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. ExTRACT-TIMI 25 compared a low-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_update_acc.mp3</guid> 
	<pubDate>Tue, 12 Dec 2006 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>12:40</itunes:duration> 
	<itunes:keywords>Acute Coronary Syndrome, TIMI 25, ExTRACT, heparin, enoxaparin</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/i8xLPYXVYvE/acc_update_acc.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/i8xLPYXVYvE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_update_acc.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/i8xLPYXVYvE/acc_update_acc.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_update_acc.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>What is the Relevance of Pulse Pressure and Arterial Stiffness?</title>
	<link>http://feedproxy.google.com/~r/accpodcast/~3/HAdgjwN5cKU/acc_arterialstiffness.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>What is the Relevance of Pulse Pressure and Arterial Stiffness?</itunes:subtitle> 
	<itunes:summary>Pulse pressure is defined as the systolic minus the diastolic pressure. This value appears, at least in some epidemiologic studies, to be superior in predictive value to the systolic or diastolic values alone.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_arterialstiffness.mp3</guid> 
	<pubDate>Tue, 5 Dec 2006 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>15:30</itunes:duration> 
	<itunes:keywords>Pulse, Pressure, Arterial, Stiffness</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/HAdgjwN5cKU/acc_arterialstiffness.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/HAdgjwN5cKU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_arterialstiffness.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/HAdgjwN5cKU/acc_arterialstiffness.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_arterialstiffness.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>Treatment Options for the Stage C Heart Failure Patient</title>
	<link>http://feedproxy.google.com/~r/accpodcast/~3/chORp-kZFlo/acc_treat_options.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Treatment Options for the Stage C Heart Failure Patient</itunes:subtitle> 
	<itunes:summary>According to the ACC/AHA guideline for the diagnosis and management of chronic heart failure, stage C includes patients with structural heart disease and symptomatic heart failure.Joining this conversation to discuss the current treatment options for patients who have stage C heart failure are Dr. Lynne Stevenson, Dr. Marvin Konstam, and Dr. Marc Semigran, all clinical cardiologists and experts in the treatment of heart failure.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_treat_options.mp3</guid> 
	<pubDate>Tue, 26 Sep 2006 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>26:04</itunes:duration> 
	<itunes:keywords>Stage c heart failure, dolph hutter, ACEIs or ARBs and beta-blockers</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/chORp-kZFlo/acc_treat_options.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/chORp-kZFlo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_treat_options.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/chORp-kZFlo/acc_treat_options.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_treat_options.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Personalizing Cardiovascular Medicine Based on Different Patient Populations</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/T_twdacOCcU/personalizing_cardio.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Personalizing Cardiovascular Medicine Based on Different Patient Populations</itunes:subtitle> 
	<itunes:summary>A discussion of the challenges to understanding racial/ethnic differences in cardiovascular risk factors and treatment outcomes.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/personalizing_cardio.mp3</guid>
	<pubDate>Tue, 19 Sep 2006 16:00:00 EST</pubDate> 
	<itunes:category text="Health" /> 
	<itunes:category text="Science" /> 
	<itunes:duration>12:10</itunes:duration> 
	<itunes:keywords>Cardiovascular medicine, patient populations, dolph hutter, Christopher o'donnell.</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/T_twdacOCcU/personalizing_cardio.mp3" fileSize="8769322" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/T_twdacOCcU" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/personalizing_cardio.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/T_twdacOCcU/personalizing_cardio.mp3" length="8769322" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/personalizing_cardio.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>Update on UA/NSTEMI Management</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/DR7l4M2b5fY/acc_conv_nstem.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Update on UA/NSTEMI Management</itunes:subtitle> 
	<itunes:summary>Update on UA/NSTEMI Management</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_nstem.mp3</guid>
	<pubDate>Tue, 9 May 2006 12:00:00 EST</pubDate>  
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>16:29</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/DR7l4M2b5fY/acc_conv_nstem.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/DR7l4M2b5fY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_nstem.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/DR7l4M2b5fY/acc_conv_nstem.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_nstem.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>Current Approaches to RAS Blockade</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/Mt-wdKJxkZY/acc_conv_ras.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Current Approaches to RAS Blockade</itunes:subtitle> 
	<itunes:summary>Current Approaches to RAS Blockade</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/novartis/acc_conv_ras.mp3</guid>
	<pubDate>Tue, 2 May 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>16:50</itunes:duration> 
	<itunes:keywords />
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/Mt-wdKJxkZY/acc_conv_ras.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/Mt-wdKJxkZY" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/novartis/acc_conv_ras.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/Mt-wdKJxkZY/acc_conv_ras.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/novartis/acc_conv_ras.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Drug Eluting Stents and Bivalirudin: Data from ADEST and Other PCI Trials</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/wObTjvEEgEM/acc_conv_adest.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Drug Eluting Stents and Bivalirudin: Data from ADEST and Other PCI Trials</itunes:subtitle> 
	<itunes:summary>Drug Eluting Stents and Bivalirudin: Data from ADEST and Other PCI Trials</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/medcompany/acc_conv_adest.mp3</guid> 
	<pubDate>Tue, 25 Apr 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>13:33</itunes:duration> 
	<itunes:keywords />
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/wObTjvEEgEM/acc_conv_adest.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/wObTjvEEgEM" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/medcompany/acc_conv_adest.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/wObTjvEEgEM/acc_conv_adest.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/medcompany/acc_conv_adest.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>Role of Direct Thrombin Inhibitors in ACS</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/8oBkzJUCppM/acc_thrombin.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Role of Direct Thrombin Inhibitors in ACS</itunes:subtitle> 
	<itunes:summary>Role of Direct Thrombin Inhibitors in ACS</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/medcompany/acc_thrombin.mp3</guid> 
	<pubDate>Tue, 18 Apr 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>14:20</itunes:duration> 
	<itunes:keywords />
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/8oBkzJUCppM/acc_thrombin.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/8oBkzJUCppM" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/medcompany/acc_thrombin.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/8oBkzJUCppM/acc_thrombin.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/medcompany/acc_thrombin.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced Thrombocytopenia</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/hIT365eHOg0/acc_conv_hit.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced Thrombocytopenia</itunes:subtitle> 
	<itunes:summary>Pathogenesis, Diagnosis, Treatment and Prevention of Heparin-induced Thrombocytopenia</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/medcompany/acc_conv_hit.mp3</guid>  
	<pubDate>Tue, 11 Apr 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>20:45</itunes:duration> 
	<itunes:keywords />
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/hIT365eHOg0/acc_conv_hit.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/hIT365eHOg0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/medcompany/acc_conv_hit.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/hIT365eHOg0/acc_conv_hit.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/medcompany/acc_conv_hit.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>ExTRACT TIMI-25</title>
	<link>http://feedproxy.google.com/~r/accpodcast/~3/KPMKhQmG9d0/acc_conv_extract.mp33</link> 
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>ExTRACT TIMI-25</itunes:subtitle> 
	<itunes:summary>ExTRACT TIMI-25</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_extract.mp33</guid> 
	<pubDate>Tue, 4 Apr 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>15:27</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/n3NXkXlzICY/acc_conv_extract.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/KPMKhQmG9d0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_extract.mp33</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/n3NXkXlzICY/acc_conv_extract.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_extract.mp3</feedburner:origEnclosureLink></item>

<item>
	<title>ACUITY Trial: Heparins Vs. Bivalirudin for ACS</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/iInWJAgII0M/acc_conv_acuity.mp3</link> 
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>ACUITY Trial: Heparins Vs. Bivalirudin for ACS</itunes:subtitle> 
	<itunes:summary>ACUITY Trial: Heparins Vs. Bivalirudin for ACS</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/medcompany/acc_conv_acuity.mp3</guid>
	<pubDate>Tue, 14 Mar 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>11:35</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/iInWJAgII0M/acc_conv_acuity.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/iInWJAgII0M" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/medcompany/acc_conv_acuity.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/iInWJAgII0M/acc_conv_acuity.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/medcompany/acc_conv_acuity.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>BNP: Understanding Its Clinical Utility</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/l1KLTiWjfKQ/acc_conv_bnp.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>BNP: Understanding Its Clinical Utility</itunes:subtitle> 
	<itunes:summary>BNP: Understanding Its Clinical Utility</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_conv_bnp.mp3</guid>
	<pubDate>Tue, 20 Dec 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>19:20</itunes:duration> 
	<itunes:keywords />
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/l1KLTiWjfKQ/acc_conv_bnp.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/l1KLTiWjfKQ" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_conv_bnp.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/l1KLTiWjfKQ/acc_conv_bnp.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_conv_bnp.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Multi-Markers Strategies for the Rapid Diagnosis of ACS</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/v8Prfr1MCG0/acc_multimarkers_conv.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Multi-Markers Strategies for the Rapid Diagnosis of ACS</itunes:subtitle> 
	<itunes:summary>Multi-Markers Strategies for the Rapid Diagnosis of ACS</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/biosite/acc_multimarkers_conv.mp3</guid>
	<pubDate>Tue, 13 Dec 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>19:20</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/v8Prfr1MCG0/acc_multimarkers_conv.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/v8Prfr1MCG0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/biosite/acc_multimarkers_conv.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/v8Prfr1MCG0/acc_multimarkers_conv.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/biosite/acc_multimarkers_conv.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Should Beta-Blockers be First-Line Therapy in Primary Hypertension?</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/HrtAxSp0jRM/acc_betablockers.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Should Beta-Blockers be First-Line Therapy in Primary Hypertension?</itunes:subtitle> 
	<itunes:summary>Should Beta-Blockers be First-Line Therapy in Primary Hypertension?</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_betablockers.mp3</guid>
	<pubDate>Tue, 6 Dec 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>15:06</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/HrtAxSp0jRM/acc_betablockers.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/HrtAxSp0jRM" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_betablockers.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/HrtAxSp0jRM/acc_betablockers.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_betablockers.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Stages A &amp; B Pre-HF: Identification and Prevention of Progression</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/WBZuVsluD48/acc_ab_progression.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Stages A &amp; B Pre-HF: Identification and Prevention of Progression</itunes:subtitle> 
	<itunes:summary>Stages A &amp; B Pre-HF: Identification and Prevention of Progression</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/novartis/acc_ab_progression.mp3</guid>
	<pubDate>Tue, 6 Dec 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>18:47</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/WBZuVsluD48/acc_ab_progression.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/WBZuVsluD48" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/novartis/acc_ab_progression.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/WBZuVsluD48/acc_ab_progression.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/novartis/acc_ab_progression.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>STEEPLE Trial: Enoxaparin Vs. UFH for Non-emergent PCI</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/Jz0ooHlnGT0/acc_steeple.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>STEEPLE Trial: Enoxaparin Vs. UFH for Non-emergent PCI</itunes:subtitle> 
	<itunes:summary>STEEPLE Trial: Enoxaparin Vs. UFH for Non-emergent PCI</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_steeple.mp3</guid>
	<pubDate>Tue, 22 Nov 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>14:30</itunes:duration> 
	<itunes:keywords /> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/Jz0ooHlnGT0/acc_steeple.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/Jz0ooHlnGT0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_steeple.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/Jz0ooHlnGT0/acc_steeple.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_steeple.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Potential Benefits with Renin Inhibitors</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/SYnSIhshmPc/acc_renin_benifits.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Potential Benefits with Renin Inhibitors</itunes:subtitle> 
	<itunes:summary>Joining this conversation to discuss the current data and potential outlook of renin inhibitors are Dr. Haralambos Gavras and Dr. Michael Weber, both thought leaders in hypertension and cardiovascular disease.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/novartis/acc_renin_benifits.mp3</guid>
	<pubDate>Tue, 10 Oct 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>14:22</itunes:duration> 
	<itunes:keywords>renin-angiotensin, vascular, Inhibitors, renin, angiotensin, AT2</itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/SYnSIhshmPc/acc_renin_benifits.mp3" fileSize="1184700" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/SYnSIhshmPc" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/novartis/acc_renin_benifits.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/SYnSIhshmPc/acc_renin_benifits.mp3" length="1184700" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/novartis/acc_renin_benifits.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Effectively Managing Non-Cardiac Chronic Pain in Patients at Risk for Cardiovascular Disease</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/MyCin1COak0/acc_chronicpain_pfiz1.mp3</link> 
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> Effectively Managing Non-Cardiac Chronic Pain in Patients at Risk for Cardiovascular Disease </itunes:subtitle> 
	<itunes:summary> Effectively Managing Non-Cardiac Chronic Pain in Patients at Risk for Cardiovascular Disease </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/pfizer/acc_chronicpain_pfiz1.mp3</guid>
	<pubDate>Tue, 6 Sep 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>Non-cardiac chronic pain, non-steroidal anti-inflammatory drugs, NSAID's, Dr. Dwight Robinson, BruceChronstein, manage patients, clinical role of COX-2 inhibitors, antiplatelet effects, aspirin, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/MyCin1COak0/acc_chronicpain_pfiz1.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/MyCin1COak0" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/pfizer/acc_chronicpain_pfiz1.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/MyCin1COak0/acc_chronicpain_pfiz1.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/pfizer/acc_chronicpain_pfiz1.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>ACC/AHA STEMI Guidelines: Judging Time and Choosing Reperfusion Methods</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/fUNxIbRc7-M/acc_conv_stemi_av.mp3</link> 
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>ACC/AHA STEMI Guidelines: Judging Time and Choosing Reperfusion Methods </itunes:subtitle> 
	<itunes:summary>ACC/AHA STEMI Guidelines: Judging Time and Choosing Reperfusion Methods </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_stemi_av.mp3</guid>
	<pubDate>Tue, 23 Aug 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>AHA, STEMI Guidelines, Sidney Smith, MD, Deepak Bhatt, MD, STEMI Patients, Pharmacological and mechanical reperfusion strategies, Fibrinolysis, primary PCI, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/fUNxIbRc7-M/acc_conv_stemi_av.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/fUNxIbRc7-M" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_stemi_av.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/fUNxIbRc7-M/acc_conv_stemi_av.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_conv_stemi_av.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The Women's Health Study: What's the Correct Dose of Aspirin for Prevention of CV Disease</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/_ZX9abFoB10/acc_womenhealth_bhc.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> The Women's Health Study: What's the Correct Dose of Aspirin for Prevention of CV Disease </itunes:subtitle> 
	<itunes:summary>The Women's Health Study: What's the Correct Dose of Aspirin for Prevention of CV Disease </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/bayer/acc_womenhealth_bhc.mp3</guid>
	<pubDate>Tue, 16 Aug 2005 12:00:00 EST</pubDate>  
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>Women and Heart Disease, The Women's Health Study, Correct Dose of Aspirin, Aspirin, Preventing Cardiovascular Disease, Cardiovascular Disease in Women, Sidney Smith, MD, Michael Gaziano, MD, non-fatal myocardial infarction, nonfatal stroke, low-dose aspirin, WHS, effectively administering aspirin, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/_ZX9abFoB10/acc_womenhealth_bhc.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/_ZX9abFoB10" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/bayer/acc_womenhealth_bhc.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/_ZX9abFoB10/acc_womenhealth_bhc.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/bayer/acc_womenhealth_bhc.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Reviewing Data from the VALIENT Trial</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/r69-TFTjr14/acc_valiant_nv.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Reviewing Data from the VALIENT Trial</itunes:subtitle> 
	<itunes:summary>Reviewing Data from the VALIENT Trial</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/novartis/acc_valiant_nv.mp3</guid>
	<pubDate>Tue, 9 Aug 2005 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>VALIENT Trial, sudden death, acute myocardial infarction, reduced left ventricular systolic function, VALsartan In Acute Myocardial Infarction, high-risk patients, angiotensin II receptor blocker, ARB, post-MI, Jay Cohn, MD, Scott Solomon, ACE inhibitors, ARB's in patients, LVD, HF, Cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/r69-TFTjr14/acc_valiant_nv.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/r69-TFTjr14" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/novartis/acc_valiant_nv.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/r69-TFTjr14/acc_valiant_nv.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/novartis/acc_valiant_nv.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Diet and Cardiovascular Disease: An evidence-Based Assessment</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/N0AmzBWesMs/acc_dietcardio.mp</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Evaluating several dietary approached and the scientific data relating to cardiovascular health</itunes:subtitle> 
	<itunes:summary> Evaluating several dietary approached and the scientific data relating to cardiovascular health </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_dietcardio.mp</guid>
	<pubDate>Wed, 25 May 2005 12:00:00 EST</pubDate>  
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>Diet and heart health, heart health, Cardiovascular disease, Laurence Sperling, MD, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/HCYeon2kBS0/acc_dietcardio.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/N0AmzBWesMs" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_dietcardio.mp</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/HCYeon2kBS0/acc_dietcardio.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_dietcardio.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Atherosclerotic Effects of Lipid-Lowering Therapy Measured By Non-invasive MRI</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/7DwdZBzQeqE/acc_lipid_therapy.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Discussing the features of a vulnerable plaque as seen by MRI and the site-specific differences of atherosclerotic plaques</itunes:subtitle> 
	<itunes:summary> Discussing the features of a vulnerable plaque as seen by MRI and the site-specific differences of atherosclerotic plaques </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_lipid_therapy.mp3</guid>
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>atherosclerotic plaques, MRI, Thoracic aortic plaque regression, lipid-lowering therapy with simvastatin, atorvastatin, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/7DwdZBzQeqE/acc_lipid_therapy.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/7DwdZBzQeqE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_lipid_therapy.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/7DwdZBzQeqE/acc_lipid_therapy.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_lipid_therapy.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The Cardiovascular Risk of COX-2 Inhibitors and Other NSAIDs: Reviewing the FDA Advisory Panel Methods, Data and Conclusions</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/MRW6ARuwGNo/acc_painmeds_pfiz.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> The Cardiovascular Risk of COX-2 Inhibitors and Other NSAIDs: Reviewing the FDA Advisory Panel Methods, Data and Conclusions </itunes:subtitle> 
	<itunes:summary> The Cardiovascular Risk of COX-2 Inhibitors and Other NSAIDs: Reviewing the FDA Advisory Panel Methods, Data and Conclusions </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/pfizer/acc_painmeds_pfiz.mp3</guid> 
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>COX-2 Inhibitors, NSAIDs, Arthritis and Drug Safety, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/MRW6ARuwGNo/acc_painmeds_pfiz.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/MRW6ARuwGNo" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/pfizer/acc_painmeds_pfiz.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/MRW6ARuwGNo/acc_painmeds_pfiz.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/pfizer/acc_painmeds_pfiz.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Revisting the COMET Trial</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/cwId5qBpW3w/acc_revisitcomet_gsk.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Discussion on why metroprolol tartrate was used at a dose of 50 mg bid and its importance when interpreting data from the COMET trial and the comparison data on myocardial and metabolic effects. </itunes:subtitle> 
	<itunes:summary> Discussion on why metroprolol tartrate was used at a dose of 50 mg bid and its importance when interpreting data from the COMET trial and the comparison data on myocardial and metabolic effects.</itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3</guid>
	<pubDate>Mon, 30 Mar 2005 12:00:00 EST</pubDate>
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>COMET Trial, myocardial and metabolic effects, metroprolol tartate, carvedilol and metoprolol, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/cwId5qBpW3w/acc_revisitcomet_gsk.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/cwId5qBpW3w" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/cwId5qBpW3w/acc_revisitcomet_gsk.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>SYNERGY: Analyzing New Data from This 10,000-Patient Trial</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/JyZEyPlqtoE/acc_synergy_av.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> SYNERGY: Analyzing New Data from This 10,000-Patient Trial </itunes:subtitle> 
	<itunes:summary> SYNERGY: Analyzing New Data from This 10,000-Patient Trial </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_synergy_av.mp3</guid>
	<pubDate>Mon, Mar 23 2005 12:00:00 EST</pubDate>  
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>SYNERGY Trial, enoxaparin, acute coronary syndrome, NSTE-ACS, antithrombin therapy, treating NSTE-ACS patients, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/JyZEyPlqtoE/acc_synergy_av.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/JyZEyPlqtoE" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_synergy_av.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/JyZEyPlqtoE/acc_synergy_av.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/sanofi-aventis/acc_synergy_av.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The Clinical Importance of Left Ventricular Mass in Hypertension</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/mJL6vckK9-U/acc_conv_clinical_pfiz.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> The Clinical Importance of Left Ventricular Mass in Hypertension </itunes:subtitle> 
	<itunes:summary> The Clinical Importance of Left Ventricular Mass in Hypertension </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/pfizer/acc_conv_clinical_pfiz.mp3</guid>
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>Hypertention, Left-ventricular mass in hypertension, lV Mass, optimve use of echocardiography, LV Measurements, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/mJL6vckK9-U/acc_conv_clinical_pfiz.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/mJL6vckK9-U" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/pfizer/acc_conv_clinical_pfiz.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/mJL6vckK9-U/acc_conv_clinical_pfiz.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/pfizer/acc_conv_clinical_pfiz.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The Effects of Anti-hypertensives in New-onset Diabetes</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/OEjGHdw2gLI/acc_antihyperdi_ab.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> The Effects of Anti-hypertensives in New-onset Diabetes </itunes:subtitle> 
	<itunes:summary> The Effects of Anti-hypertensives in New-onset Diabetes </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/abbott/acc_antihyperdi_ab.mp3</guid>
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate> 
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>Anti-hypertensives, diabetes, diabetes onset, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/OEjGHdw2gLI/acc_antihyperdi_ab.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/OEjGHdw2gLI" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/abbott/acc_antihyperdi_ab.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/OEjGHdw2gLI/acc_antihyperdi_ab.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/abbott/acc_antihyperdi_ab.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>A-HeFT: Clinical Implications for Heart Failure Patients</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/fHFS9Wd7p0w/acc_aheft.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle>Brief summary of the major findings and clinical conclusions from A-HeFT</itunes:subtitle> 
	<itunes:summary> Brief summary of the major findings and clinical conclusions from A-HeFT </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/acc_aheft.mp3</guid>
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate>
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>A-HeFT, Heart Failure, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/fHFS9Wd7p0w/acc_aheft.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/fHFS9Wd7p0w" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/acc_aheft.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/fHFS9Wd7p0w/acc_aheft.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/acc_aheft.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>The GEMINI Trial: Comparing the Glycemic Effects of Carvedilol and Metoprolol in Hypertensive Patients with Diabetes</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/cwId5qBpW3w/acc_revisitcomet_gsk.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> The GEMINI Trial: Comparing the Glycemic Effects of Carvedilol and Metoprolol in Hypertensive Patients with Diabetes </itunes:subtitle> 
	<itunes:summary> The GEMINI Trial: Comparing the Glycemic Effects of Carvedilol and Metoprolol in Hypertensive Patients with Diabetes </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3</guid>
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate>
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>GEMINI Trial, Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives, Beta-Blockers, glycemic and metabolic control, Type II diabetes, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology</itunes:keywords>
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/cwId5qBpW3w/acc_revisitcomet_gsk.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/cwId5qBpW3w" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/cwId5qBpW3w/acc_revisitcomet_gsk.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/gsk/acc_revisitcomet_gsk.mp3</feedburner:origEnclosureLink></item>
<item>
	<title>Treating NSTEMI When Emergency PCI is Not and Option</title> 
	<link>http://feedproxy.google.com/~r/accpodcast/~3/0twgMWtDk_w/acc_treatnstemi_av.mp3</link>
	<itunes:author>Adolph M. Hutter, Jr., MD</itunes:author> 
	<itunes:subtitle> Treating NSTEMI When Emergency PCI is Not and Option </itunes:subtitle> 
	<itunes:summary> Treating NSTEMI When Emergency PCI is Not and Option </itunes:summary> 
	 
	<guid isPermaLink="false">http://www.healthology.biz/acc/podcast/aventis/acc_treatnstemi_av.mp3</guid>
	<pubDate>Mon, 14 Aug 2006 12:00:00 EST</pubDate>
	<itunes:category text="Science &amp; Medicine" /> 
	<itunes:duration>7:00</itunes:duration> 
	<itunes:keywords>ACS, ACS patients, cardiology, Cardiologists, Hypertension, Chronic Heart Failure, Coronary Heart Disease, Cardiovascular Disease, Cholesterol Management, Adolph Hutter, MD, American College of Cardiology, Heart Failure, Coronary, Interventional Cardiology </itunes:keywords> 
<media:content url="http://feedproxy.google.com/~r/accpodcast/~5/0twgMWtDk_w/acc_treatnstemi_av.mp3" fileSize="4000000" type="audio/mp3" /><description>&lt;img src="http://feeds.feedburner.com/~r/accpodcast/~4/0twgMWtDk_w" height="1" width="1"/&gt;</description><feedburner:origLink>http://www.healthology.biz/acc/podcast/aventis/acc_treatnstemi_av.mp3</feedburner:origLink><enclosure url="http://feedproxy.google.com/~r/accpodcast/~5/0twgMWtDk_w/acc_treatnstemi_av.mp3" length="4000000" type="audio/mp3" /><feedburner:origEnclosureLink>http://www.healthology.biz/acc/podcast/aventis/acc_treatnstemi_av.mp3</feedburner:origEnclosureLink></item>
<media:credit role="author">Adolph M. Hutter, Jr., MD</media:credit><media:rating>nonadult</media:rating><media:description type="plain">American College of Cardiology presents Conversations with Experts, a series of 20-minute interactive discussions between though-leaders on topics of importance to the medical community</media:description></channel>
</rss>
